ovarian

Related by string. Ovarian * * ovarian tissue . Ovarian Cancer Research . recurrent ovarian cancer . relapsed ovarian cancer . benefitting ovarian cancer . ovarian cancers . resistant ovarian cancer . ovarian cysts . ovarian cyst . epithelial ovarian cancer . Ovarian Cancer Coalition . premature ovarian . Ovarian Cancer Awareness Month . Ovarian Cancer Screening *

Related by context. All words. (Click for frequent words.) 65 endometrial 62 egg follicles 61 ovary 60 ovarian function 60 breast carcinoma 59 Ovarian 59 ovarian cancer 58 ovarian cancers 58 endometrial cancers 58 ovaries 57 premature ovarian 57 pancreatic lung 57 prostate carcinoma 57 follicle stimulating hormone 56 lobular carcinoma 56 breast tumors 56 atypical hyperplasia 56 oophorectomy 56 invasive carcinoma 56 Sertoli cells 56 intestinal polyps 56 prostate cancers 56 recurrent ovarian 56 pancreatic adenocarcinoma 56 epithelial ovarian cancer 56 chromosomal abnormalities 55 aneuploidy 55 endometrial cancer 55 follicle stimulating hormone FSH 55 ovarian hormones 55 ovulation induction 55 bilateral oophorectomy 55 breast tissue 55 pancreatic 55 endometrium 55 cisplatin resistant 55 thyroid nodules 55 epithelial ovarian 55 androgen 55 colorectal tumor 55 uterine tumors 55 tumors 54 ovulatory cycles 54 pituitary hormones 54 oocytes 54 GISTs 54 distant metastases 54 cervical carcinoma 54 breast carcinomas 54 precancerous 54 seminoma 54 urothelial carcinoma 54 ovarian carcinoma 54 testicular cancers 54 BRCA deficient 54 HER2 positive breast cancer 54 carcinoma 54 colorectal cancers 54 HER2 neu 54 uterine cancers 54 mammary cancers 54 lobular breast cancer 54 sFlt 1 53 endometrial hyperplasia 53 pancreatic ovarian 53 situ LCIS 53 pancreatic islet 53 operable breast cancer 53 colorectal cancer 53 trophoblast cells 53 prostate tissue 53 malignancy 53 oocyte 53 mucinous 53 endometrial lining 53 recurrent miscarriage 53 Endometrial 53 polycystic ovary syndrome PCOS 53 prostate specific 53 nephron 53 luteal 53 PCa 53 varicocele 53 uterine 53 androgens 53 hyperplasia 53 ductal 53 endometriosis 53 gonadal 53 adenomatous 53 atypia 53 WT1 53 primordial follicles 53 tumor recurrence 53 estrogen 53 ovarian stimulation 53 breast endometrial 53 haematopoietic 53 pre cancerous 53 liver metastasis 53 metastatic prostate cancer 53 ovarian tumors 53 prophylactic mastectomy 53 gonadotropins 53 premature menopause 52 hereditary breast cancer 52 urothelial cancer 52 breast cancers 52 testicular 52 invasive breast cancer 52 adenoma 52 lobular cancer 52 HNSCC 52 aromatase 52 lung adenocarcinoma 52 corpus luteum 52 precursor lesions 52 adjuvant radiotherapy 52 ectopic 52 testicular germ cell 52 aneuploid 52 radiosensitivity 52 spermatogenesis 52 leukemic cell 52 hamartoma 52 colon tumors 52 colorectal carcinoma 52 testis 52 leiomyoma 52 breast cancer 52 bladder cancers 52 DCIS 52 bladder tumors 52 CD# + [002] 52 noncancerous tumors 52 pre menopausal 52 LRP5 52 premalignant 52 polycystic ovary syndrome 52 colorectal tumors 52 HER-2/neu 52 bowel cancers 52 BRCA1 52 ovulations 52 ovaries removed 52 tumorigenesis 52 tumor 52 Ductal carcinoma 52 Stat5 52 teratoma 52 granulosa cells 52 prostate cancer PCa 52 haematopoietic stem cell 52 liver metastases 52 glandular tissue 52 breast ovarian 52 adenocarcinomas 52 lymphocyte 52 endogenous estrogen 52 axillary dissection 52 fallopian tube cancers 52 malignancies 52 HER2 receptor 52 hamartomas 52 ductal breast cancer 52 BRCA1 mutations 52 premenopausal breast cancer 52 testicular sperm 51 nodal metastasis 51 prostate cancer 51 ovulation 51 HGPIN 51 Oestrogen 51 undifferentiated stem cells 51 tumoral 51 VEGF expression 51 peritoneal carcinomatosis 51 mammary tumors 51 pAkt 51 ovarian lung 51 lung adenocarcinomas 51 sarcomatoid 51 neoplastic 51 hematopoietic cell 51 micrometastases 51 parathyroid 51 metastatic disease 51 undergoing hysterectomy 51 ovarian hyperstimulation 51 neoplasia 51 steroidogenesis 51 premalignant lesions 51 LHRH receptor positive 51 orchiectomy 51 MSH2 51 ovariectomy 51 endothelial cell 51 preeclamptic women 51 ectopic pregnancy 51 HER2 gene 51 c MYC 51 incidentalomas 51 BRCA2 mutation carriers 51 ductal adenocarcinoma 51 embryonal 51 axillary lymph nodes 51 chromosomally abnormal 51 metastatic 51 liver fibrosis 51 gastric carcinoma 51 progesterone hormone 51 metastatic tumors 51 ovarian follicles 51 androgen receptor AR 51 metastatic prostate 51 ductal carcinoma 51 p#INK#a 51 embryo implantation 51 HER2 51 osteoblast 51 Lymph node 51 precancerous condition 51 gastric cancer 51 invasive ductal 51 p# Shc 51 ovarian hyperstimulation syndrome 51 hormonal therapy 51 Sox9 51 renal cell carcinomas 51 prostatic 51 ovarian tissue 51 sentinel lymph node biopsy 51 chemosensitivity 51 secretes insulin 51 thromboembolic disease 51 carcinoid tumor 51 nonmelanoma skin cancers 51 advanced adenoma 51 IVF ICSI 51 colorectal polyps 51 mutant p# 51 leukapheresis 51 histological subtype 51 HER2 protein 51 involution 51 prostate cancer CaP 51 lymph node metastasis 51 malignant transformation 50 Inhibin B 50 colorectal cancer CRC 50 BRCA1 gene 50 metastatic cancer 50 Malignant tumors 50 HER2 overexpression 50 postmenopausal breast cancer 50 thyroid stimulating hormone 50 bone metastasis 50 β catenin 50 p# mutations 50 leukaemic stem cells 50 primordial germ cells 50 hormonal 50 estrogen hormone 50 malignant tumors 50 Notch pathway 50 colon cancer 50 undergoing IVF 50 mRNA expression 50 GnRH agonists 50 prophylactic mastectomies 50 androgen independent 50 hedgehog pathway 50 antral follicles 50 ascites 50 female hormone estrogen 50 ovulatory 50 thyroglobulin 50 breast uterine 50 cystectomy 50 thyroid hormone 50 p# mutation 50 lobular 50 progesterone receptor negative 50 fetal malformations 50 premenopausal 50 uterus fallopian tubes 50 adrenal function 50 nodal metastases 50 pro angiogenic 50 contralateral breast 50 endometrial carcinoma 50 leiomyomas 50 antigen PSA 50 hormone estrogen 50 neoadjuvant therapy 50 myoma 50 postmenopausal estrogen 50 carcinomas 50 chromosomally normal 50 lymphangiogenesis 50 prostate ovarian 50 endocrine tumors 50 chemopreventive agent 50 metastases 50 BRCA mutation carriers 50 inhibin 50 prostate tumor 50 lobular carcinomas 50 genotoxic stress 50 papillary 50 vitro maturation 50 acute myelogenous leukemia AML 50 atherosclerotic lesions 50 epididymal 50 progestogens 50 placental 50 DNA methylation patterns 50 uterine ovarian 50 proximal tubules 50 metastatic gastric 50 testicular tumors 50 hMG 50 suppressor gene 50 leukaemias 50 neoplastic lesions 50 anti apoptotic proteins 50 recurrent ovarian cancer 50 subfertility 50 hormone receptor status 50 radioiodine therapy 50 distant metastasis 50 prostate adenocarcinoma 50 conceptus 50 androgen dependent 50 prostate pancreatic 50 acinar 50 ovarian malignancy 50 hepatocellular carcinoma 50 thyroid carcinoma 50 cysts 50 NSCLC 50 thyroid function 50 FGFR2 gene 50 specific antigen 50 Leydig cell 50 breast cancer metastasis 50 hormonal stimulation 50 autoantibodies 50 mammary cells 50 parenchyma 50 HbF 50 epithelial tissues 50 uPA 50 fibrocystic 50 NF1 50 BRCA mutations 50 serous ovarian cancer 50 thyroid dysfunction 50 pre cancerous lesions 50 ovarian breast 50 uterine tissue 50 tumor biopsies 50 gastric cancers 50 invasive lobular carcinoma 50 choriocarcinoma 50 bone metabolism 50 noncancerous 50 p# MAPK 50 glioblastoma tumor 50 neoadjuvant chemotherapy 49 Hh pathway 49 fine needle aspiration 49 ectopic expression 49 lung tumors 49 mitochondrial fusion 49 hormone 49 adipocyte 49 GSTT1 49 basal cells 49 menopausal 49 triiodothyronine 49 glandular 49 syngeneic 49 activin 49 benign breast 49 subfertile 49 mesangial 49 Ovary removal 49 carcinogenesis 49 epithelial cancers 49 ectoderm 49 thyroid hormone levels 49 oocytes eggs 49 hematopoietic stem cell 49 situ DCIS 49 varicoceles 49 Hashimoto thyroiditis 49 hepatic stellate cells 49 egg retrieval 49 anovulation 49 sonographically guided 49 histopathologic examination 49 COX2 49 Leydig cells 49 anovulatory 49 IUGR 49 autologous transplants 49 sentinel node 49 proto oncogene 49 ovulated 49 pre cancerous lesion 49 vascularization 49 hepatocyte 49 cancers 49 SPINK1 49 endostatin 49 fibroids 49 orthotopic 49 tubal 49 prognostic indicator 49 CMV infections 49 lung carcinomas 49 ASCUS 49 ALCL 49 prostate breast 49 tumor histology 49 metaplasia 49 pancreatic cancers 49 polycystic ovarian syndrome PCOS 49 somatic mutations 49 oncoprotein 49 cervical lesions 49 prostate cancer CRPC 49 tumor suppressor gene 49 renal tumors 49 mesotheliomas 49 pheochromocytoma 49 chromosomal anomalies 49 benign growths 49 S#A# [002] 49 allogeneic hematopoietic stem cell 49 colorectal 49 Androgen 49 pituitary hormone 49 ductal carcinomas 49 peritoneal cancer 49 male hormones androgens 49 metachronous 49 FGFR1 49 PARP inhibition 49 granulocyte 49 mosaicism 49 hydronephrosis 49 intrahepatic 49 male hormone androgen 49 xenograft tumors 49 tissue homeostasis 49 aneuploidies 49 bile duct cancers 49 specific antigen PSA 49 adjuvant radiation 49 oestrogens 49 malignant growths 49 chorionic villi 49 neovascularization 49 hematopoietic cancers 49 plasma kallikrein 49 PTEN gene 49 EGFR pathway 49 lymphomas leukemias 49 pancreatic cysts 49 oophorectomy removal 49 cyclin E 49 hepatic fibrosis 49 colorectal gastric 49 preimplantation genetic screening 49 chlamydial 49 ncRNA 49 carcinoid 49 insulin secreting beta 49 xenograft models 49 KRAS oncogene 49 pituitary tumors 49 RhD negative 49 transgene expression 49 gastrointestinal stromal tumors GISTs 49 JAK2 49 cervical lymph nodes 49 chemoresistant 49 fallopian tube carcinoma 49 vestibular schwannomas 49 BCL#A 49 castrated mice 49 atypical ductal hyperplasia 49 lymph node metastases 49 mesenchymal cells 49 pathologic 49 serum prostate 49 hormone FSH 49 BRCA1 BRCA2 49 PrPSc 49 chondrosarcoma 49 anthracyclines 49 melanocytes 49 transitional cell carcinoma 49 fertility 49 bladder prostate 49 pre malignant lesions 49 neoplastic cells 49 NSCLC tumors 49 precancerous cervical 49 AGTR1 49 pancreatic endocrine 49 orchidectomy 49 Androgen deprivation therapy 49 CMV disease 49 Heterozygous 49 ERCC1 49 undergone hysterectomy 49 KRAS mutations 49 ovarian tumor 49 fibroadenoma 49 HUVEC 49 lymph node 49 RANKL 48 abnormal cervical 48 oncogenic transformation 48 myoepithelial 48 lung metastasis 48 prostate walnut 48 luteinizing hormone LH 48 hormone receptor negative 48 pleural fluid 48 fibroids endometriosis 48 chromosomal instability 48 CTGF 48 eIF 4E 48 BRCA2 48 spinocerebellar ataxia 48 myeloperoxidase 48 basal cell nevus syndrome 48 TGF ß1 48 EBRT 48 FGFR2 48 mutated K ras 48 estrogen receptor beta 48 unexplained infertility 48 MGMT gene 48 hormone progesterone 48 ovulate 48 prognostic significance 48 cytological 48 glomerular 48 ADPKD 48 androgen receptors 48 solid tumors 48 epithelial tumors 48 BRCA mutation 48 lymphatic tissue 48 diagnostic biomarker 48 calcium homeostasis 48 oocyte retrieval 48 prostate 48 infertility 48 intracerebral 48 melanocyte 48 BRCA gene mutation 48 telomere lengths 48 morphologic 48 NF kB pathway 48 fibroblast 48 F FDG PET 48 parathyroid carcinoma 48 adipose fat 48 EGFR receptor 48 CEACAM1 48 Amniocentesis 48 lymphoid tissue 48 Raf MEK ERK 48 intraductal 48 histone acetylation 48 mitochondrial mutations 48 lobular involution 48 metastatic colorectal 48 malignant prostate 48 rectal cancers 48 hormone secreting 48 pulmonary metastases 48 hypothalamic pituitary 48 sized gland 48 endometrial tissue 48 transplantation HSCT 48 proximal colon 48 chimerism 48 progranulin 48 adenomas 48 vWF 48 pre eclamptic 48 TNFalpha 48 squamous cell lung cancer 48 JAK3 48 Radical prostatectomy 48 BRCA2 carriers 48 metastasis 48 estrogen receptors 48 pulmonary metastasis 48 lymphadenopathy 48 metastatic breast cancer 48 E cadherin expression 48 OGG1 48 tunica vaginalis 48 xenografts 48 Mesenchymal 48 preeclampsia 48 hypermethylation 48 breast ovary 48 p# activation 48 gastric cardia 48 leukaemic cells 48 polycystic kidneys 48 effector memory 48 hyperparathyroidism 48 intact parathyroid hormone 48 ovary tissue 48 endometrioid 48 genistein 48 oesophageal adenocarcinoma 48 estrogen receptor negative 48 localized renal 48 miR #a [001] 48 untreated celiac disease 48 APOL1 48 hematopoietic 48 menopause 48 cell carcinomas 48 post menopausal 48 hormone therapy estrogen 48 colon rectal cancer 48 renal 48 K ras gene 48 androgen deprivation 48 pDCs 48 metastatic lung cancer 48 germline stem cells 48 ovarian uterine 48 angiosarcoma 48 factor G CSF 48 androgen hormone 48 antiangiogenic 48 mammographic density 48 spermatogonia 48 thymus 48 prostate carcinomas 48 retroperitoneal 48 gene amplification 48 ovarian hyperstimulation syndrome OHSS 48 cytologic 48 aneuploidy screening 48 transfusion syndrome 48 cancerdefine 48 P cadherin 48 oncogenesis 48 miRNA expression 48 colorectal adenoma 48 C EBP alpha 48 transabdominal 48 primary peritoneal 48 membranous nephropathy 48 epithelial cell 48 localized prostate cancer 48 sentinel node biopsy 48 leukocyte 48 uterine fibroid embolization 48 epithelial tissue 48 plasma folate 48 medically inoperable 48 nonsmall cell lung cancer 48 cellularity 48 kidney cysts 48 pancreatic tumor 48 embryo 48 thyroid 48 transthyretin 48 serum IgE 48 singleton pregnancy 48 chlamydial infection 48 scintigraphic 48 basal cell carcinomas 48 nucleated cells 48 cancerous breast 48 Follicle Stimulating Hormone 48 colorectal pancreatic 48 embryonic tissues 48 CIN2 + 48 blastomeres 48 postoperative mortality 48 vulvar intraepithelial neoplasia 48 papillary renal cell carcinoma 48 prostate lung 48 GNAQ 48 blocked fallopian tubes 48 myeloproliferative disorder 48 multiple gestations 48 flavopiridol 48 carcinoembryonic antigen 48 mammary glands 48 fibrocystic disease 48 lymph node involvement 48 HER2 expression 48 lymphocyte activation 48 salpingo oophorectomy 48 EGFR protein 48 Wnt signaling 48 trophoblasts 48 overexpression 48 neoadjuvant 48 PITX2 48 estrogen deficiency 48 hepatectomy 48 pluripotent embryonic 48 hematopoietic cells 48 normal karyotype 48 proliferative 48 pancreatic islet cell 48 nonproliferative 48 Clusterin 48 osteoclast 48 aromatase enzyme 48 HER2 positive tumors 48 prostate tumors 48 estrogenic 48 anti Mullerian hormone 48 breast epithelial cells 48 HER2 positive cancers 48 colon cancers 48 myofibroblasts 48 tibolone 48 microglial 48 EUS FNA 48 Metastases 48 vitro 48 meningioma 48 oocyte cryopreservation 48 tumorigenic 48 breast cancer genes BRCA1 48 hormone estradiol 48 allogeneic stem cell 48 metastatic RCC 48 adrenal hormone 48 neoplasms 48 neoplasias 48 grade cervical intraepithelial 48 preventative mastectomy 48 ADAMTS# 48 eNOS 48 PGE2 48 pituitary adenoma 48 Akt1 48 aneuploid cells 48 Peutz Jeghers syndrome 48 hematopoietic blood 48 advanced neoplasia 48 myelomeningocele 48 myeloablative 47 node metastasis 47 stem cell differentiation 47 factor PlGF 47 IGF IR 47 molar pregnancy 47 undescended testes 47 GATA3 47 insulin secreting cells 47 hypoxic tumor 47 granulosa cell 47 proteoglycan 47 gynecological cancers 47 vaginal flora 47 Sertoli cell 47 endometrial cells 47 HER2 positive 47 pretransplant 47 Heavy menstrual bleeding 47 pancreatic tissue 47 luminal cells 47 preoperative chemotherapy 47 renal agenesis 47 placenta accreta 47 hormonal treatments 47 TGF β 47 platelet activation 47 mtDNA mutations 47 enucleated 47 insulin secreting 47 PTHrP 47 Adjuvant chemotherapy 47 CMV infection 47 lymphoid cells 47 β cell 47 skeletal metastases 47 serum testosterone levels 47 motoneurons 47 Akt activation 47 HER2 receptors 47 antibody mediated 47 epithelia 47 polycystic ovaries 47 Fallopian tube 47 cancerous enlargement 47 colorectal adenomas 47 estrogen receptor 47 female hormone progesterone 47 antioxidant enzyme 47 Papillary 47 precancerous tumors 47 breast colon 47 breast lobules 47 squamous cell carcinoma SCC 47 allogenic 47 colorectal polyp 47 malignant pleural mesothelioma 47 hormonally sensitive 47 ependymoma 47 mammographic breast density 47 circadian clock genes 47 IGF 1R 47 papillary carcinoma 47 testes 47 pCR 47 BRCA2 mutations 47 sonographic evaluation 47 distal colon cancer 47 RhD 47 androgenic hormones 47 BRCA1 mutation carriers 47 embryogenesis 47 radial glia 47 reproductive hormones 47 haematological cancers 47 ovarian pancreatic 47 IL 1ß 47 testicular function 47 cervical lymph node 47 hypervascular 47 urothelial 47 Rh factor 47 PECAM 1 47 pancreatic prostate 47 melanoma tumors 47 neurofibroma 47 CIN3 47 female genital tract 47 mesenchymal 47 GSTP1 47 immunohistochemical staining 47 cytomegalovirus infections 47 bone resorption 47 tumor cells 47 biopsied embryos 47 abnormal uterine bleeding 47 endometriosis ovarian cysts 47 hypogonadal 47 serum PSA 47 alpha fetoprotein AFP 47 ovulates 47 masectomy 47 nephrogenic 47 B lymphocyte 47 advanced adenomas 47 clinically insignificant 47 liver cancer 47 mTOR inhibitors 47 metastatic carcinoma 47 CYP#D# genotype 47 cystic lesions 47 CYP# [002] 47 biochemical recurrence 47 neuroblastoma tumors 47 micrometastasis 47 GnRH 47 receptor gamma 47 apoptosis induced 47 retransplantation 47 osteoporotic 47 tumor metastasis 47 benign noncancerous 47 euthyroid 47 chemopreventive 47 pancreatic carcinoma 47 Immunosuppressive drugs 47 allogeneic 47 invasive lobular 47 cryo preserved 47 Hair follicles 47 SOX9 47 milk ducts 47 neuroendocrine tumors 47 androgen hormones 47 urolithiasis 47 ductal lavage 47 chromosomal mutations 47 gastrointestinal cancers 47 Rectal cancer 47 breast cancer recurrence 47 fetal chromosomal 47 esophageal carcinoma 47 ovarian follicle 47 uterine cervix 47 gynecologic cancers 47 seminal vesicle 47 relapsed ALL 47 Notch1 47 GnRH agonist 47 hepatocellular 47 irregular menstrual cycles 47 induce ovulation 47 cyclooxygenase 2 47 benign lesions 47 adipocyte differentiation 47 Carcinoid tumors 47 lymphocytes 47 endometrial tumors 47 amnion 47 Polycystic 47 mesothelial cells 47 relapsed ovarian cancer 47 node metastases 47 cancerous lumps 47 reproductive tracts 47 transvaginal 47 IL 1beta 47 colon rectal 47 pre eclampsia 47 metastatic basal cell 47 TIMP 47 BMP signaling 47 dysplastic 47 IVF embryo 47 kidney allograft 47 follicles 47 cell carcinoma 47 ductal lobular 47 hedgehog signaling 47 Immunohistochemical analysis 47 heterotaxy 47 carotid plaques 47 adrenal cortex 47 eggs oocytes 47 phenotypic expression 47 GRK2 47 SOCS2 47 adipose cells 47 albuminuria 47 adenomatous polyps 47 cellular metabolism 47 HeLa cell 47 primitive neuroectodermal tumor 47 PTEN protein 47 tumor microenvironment 47 seminal vesicles 47 humoral immunity 47 hematological disorders 47 ErbB2 47 Placental 47 cervical dysplasia 47 cell transplantation 47 epigenetic changes 47 IM progesterone 47 liver 47 antitumor effect 47 anti androgen 47 lactate dehydrogenase 47 MSMB 47 metastatic lesion 47 tumors GIST 47 primary ovarian insufficiency 47 metabolomic profiles 47 oesophageal 47 PALB2 47 4E BP1 47 impair fertility 47 fatty acid oxidation 47 ERK1 2 47 leukocyte recruitment 47 prolactin 47 pelvic ultrasound 47 cardiomyocyte 47 estrogen metabolism 47 poly ADP ribose polymerase 47 pheochromocytomas 47 microsatellite instability 47 GM CSF 47 ACOG guidelines 47 trophoblast 47 testicular biopsy 47 basal cell carcinoma BCC 47 tumor angiogenesis 47 Bcl xL 47 poorer prognosis 47 progesterone receptor

Back to home page